| Neonatal-onset multisystem inflammatory disease responsive to interleukin-1β inhibition R Goldbach-Mansky, NJ Dailey, SW Canna, A Gelabert, J Jones, BI Rubin, ... New England Journal of Medicine 355 (6), 581-592, 2006 | 1059 | 2006 |
| The hospital water supply as a source of nosocomial infections: a plea for action EJ Anaissie, SR Penzak, MC Dignani Archives of internal medicine 162 (13), 1483-1492, 2002 | 585 | 2002 |
| Enhanced neonatal Fc receptor function improves protection against primate SHIV infection SY Ko, A Pegu, RS Rudicell, Z Yang, MG Joyce, X Chen, K Wang, S Bao, ... Nature 514 (7524), 642-645, 2014 | 375 | 2014 |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy B Moriyama, AO Obeng, J Barbarino, SR Penzak, SA Henning, SA Scott, ... Clinical Pharmacology & Therapeutics 102 (1), 45-51, 2017 | 348 | 2017 |
| Depression in patients with HIV infection SR Penzak, YS Reddy, SR Grimsley American Journal of Health-System Pharmacy 57 (4), 376-386, 2000 | 240 | 2000 |
| Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis ME Cho, DC Smith, MH Branton, SR Penzak, JB Kopp Clinical Journal of the American Society of Nephrology 2 (5), 906-913, 2007 | 237 | 2007 |
| Adverse interactions between antifungal azoles and vincristine: review and analysis of cases B Moriyama, SA Henning, J Leung, O Falade‐Nwulia, P Jarosinski, ... Mycoses 55 (4), 290-297, 2012 | 178 | 2012 |
| Hyperlipidemia associated with HIV protease inhibitor use: pathophysiology, prevalence, risk factors and treatment SR Penzak, SK Chuck Scandinavian journal of infectious diseases 32 (2), 111-123, 2000 | 175 | 2000 |
| Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients PO Gubbins, G Krishna, A Sansone-Parsons, SR Penzak, L Dong, ... Antimicrobial agents and chemotherapy 50 (6), 1993-1999, 2006 | 173 | 2006 |
| Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects SM Robertson, RT Davey, J Voell, E Formentini, RM Alfaro, SR Penzak Current medical research and opinion 24 (2), 591-599, 2008 | 162 | 2008 |
| Seville (sour) orange juice: synephrine content and cardiovascular effects in normotensive adults SR Penzak, MW Jann, JA Cold, YY Hon, HD Desai, BJ Gurley The Journal of Clinical Pharmacology 41 (10), 1059-1063, 2001 | 158 | 2001 |
| The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome DH McDermott, Q Liu, J Ulrick, N Kwatemaa, S Anaya-O'Brien, SR Penzak, ... Blood, The Journal of the American Society of Hematology 118 (18), 4957-4962, 2011 | 157 | 2011 |
| Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV‐infected patients in Uganda SR Penzak, G Kabuye, P Mugyenyi, F Mbamanya, V Natarajan, RM Alfaro, ... HIV medicine 8 (2), 86-91, 2007 | 153 | 2007 |
| Influence of Panax ginseng on Cytochrome P450 (CYP)3A and P‐glycoprotein (P‐gp) Activity in Healthy Participants CY Malati, SM Robertson, JD Hunt, C Chairez, RM Alfaro, JA Kovacs, ... The Journal of Clinical Pharmacology 52 (6), 932-939, 2012 | 143 | 2012 |
| Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV LW Musselwhite, V Sheikh, TD Norton, A Rupert, BO Porter, SR Penzak, ... Aids 25 (6), 787-795, 2011 | 105 | 2011 |
| Safety, tolerability, and pharmacokinetics of high-dose idebenone in patients with Friedreich ataxia NA Di Prospero, CJ Sumner, SR Penzak, B Ravina, KH Fischbeck, ... Archives of neurology 64 (6), 803-808, 2007 | 98 | 2007 |
| Safety and efficacy of HMG‐CoA reductase inhibitors for treatment of hyperlipidemia in patients with HIV infection SR Penzak, SK Chuck, GV Stajich Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20 (9 …, 2000 | 95 | 2000 |
| Stenotrophomonas (Xanthomonas) maltophilia: A Multidrug‐Resistant Nosocomial Pathogen SR Penzak, BJ Abate Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 17 (2 …, 1997 | 88 | 1997 |
| Efavirenz induces CYP2B6-mediated hydroxylation of bupropion in healthy subjects SM Robertson, F Maldarelli, V Natarajan, E Formentini, RM Alfaro, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 49 (5), 513-519, 2008 | 85 | 2008 |
| Prednisolone pharmacokinetics in the presence and absence of ritonavir after oral prednisone administration to healthy volunteers SR Penzak, E Formentini, RM Alfaro, M Long, V Natarajan, J Kovacs JAIDS Journal of Acquired Immune Deficiency Syndromes 40 (5), 573-580, 2005 | 80 | 2005 |
